Jeff Pettey, MD
Ophthalmology · Slc, UTNPI 1346494911
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,125 of the $19,089 with a category attached, or 68.8%. 11 manufacturers reported payments, led by Lensar, Inc. at 33.2% of the total. Reporting peaked in 2023 at $5,255 and has fallen 95.9% since, to $217 in 2025. Among ophthalmology clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 30 payments — averaging $636.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lensar, Inc.$6K
- Johnson & Johnson Surgical Vision, Inc.$5K
- Carl Zeiss Meditec, Inc.$3K
- Alcon$2K
- AbbVie$1K
- Bausch & Lomb Americas Inc.$625
- plus $486 from 5 others
What the payments were for
- Consulting fees$13,12569%
- Speaking & faculty fees$2,87515%
- Travel & lodging$1,0455%
- Food & beverage$2,04411%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lensar, Inc. | 4 | $6,342 |
| Johnson & Johnson Surgical Vision, Inc. | 7 | $5,047 |
| Carl Zeiss Meditec, Inc. | 3 | $3,174 |
| Alcon | 5 | $1,927 |
| AbbVie | 2 | $1,489 |
| Bausch & Lomb Americas Inc. | 1 | $625 |
| Carl Zeiss Meditec USA, Inc. | 4 | $199 |
| NEW World Medical,inc. | 1 | $122 |
| Johnson & Johnson Vision Care, Inc. | 1 | $115 |
| Dutch Ophthalmic, USA | 1 | $26 |
| Sight Sciences, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LENSAR LASER SYSTEM$6,342
- Whitestar Phacoemulsficiation System$2,545
- QUATERA 700$2,498
- VERACITY SURGICAL$2,494
- VisuMax$2,380
- XEN GLAUCOMA TREATMENT SYSTEM$1,489
- XIIDRA$625
- MIEBO$625
- enVista MX60 IOL$625
- Tecnis Simplicity$241
- ARTEVO 800$114
- CALLISTO eye$114
- Centurion$108
How this compares
$19,089 in reported general payments places this provider in the 90th percentile of 191 ophthalmology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 60 | $2,488 |
| Ketorolac Tromethamine | 17 | $1,097 |
| Latanoprost | 58 | $672 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 14 | $282 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Slc
- Albert VitaleSlc$8K
- Iqbal AhmedSalt Lake City$895K
- Robert CionniSalt Lake City$161K
- Ron LordSt. George$61K
- Zachary ZavodniSalt Lake City$51K
- Majid MoshirfarSalt Lake City$44K
- Marc Steffen Schmitz-ValckenbergSalt Lake City$43K
- Rachel SimpsonSalt Lake City$39K
- Austin NakatsukaSalt Lake City$27K
- Phillip HoopesDraper$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.